Leigha Senter

10.1k total citations
74 papers, 2.2k citations indexed

About

Leigha Senter is a scholar working on Genetics, Oncology and Reproductive Medicine. According to data from OpenAlex, Leigha Senter has authored 74 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Genetics, 23 papers in Oncology and 22 papers in Reproductive Medicine. Recurrent topics in Leigha Senter's work include BRCA gene mutations in cancer (46 papers), Ovarian cancer diagnosis and treatment (21 papers) and Cancer Genomics and Diagnostics (17 papers). Leigha Senter is often cited by papers focused on BRCA gene mutations in cancer (46 papers), Ovarian cancer diagnosis and treatment (21 papers) and Cancer Genomics and Diagnostics (17 papers). Leigha Senter collaborates with scholars based in United States, Canada and Poland. Leigha Senter's co-authors include Albert de la Chapelle, Henry T. Lynch, Steven A. Narod, Jan Lubiński, Nadine Tung, Heather Hampel, Pål Møller, Mark Clendenning, Ritu Salani and William D. Foulkes and has published in prestigious journals such as Gastroenterology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Leigha Senter

70 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leigha Senter United States	23	971	925	904	688	474	74	2.2k
Siranoush Manoukian Italy	26	1.3k 1.4×	435 0.5×	637 0.7×	798 1.2×	992 2.1×	81	2.6k
B A Ponder United Kingdom	25	1.3k 1.4×	444 0.5×	745 0.8×	483 0.7×	1.1k 2.3×	39	2.7k
Carrie Snyder United States	22	1.2k 1.2×	886 1.0×	1.1k 1.2×	707 1.0×	588 1.2×	58	2.6k
Shirley V. Hodgson United Kingdom	29	1.2k 1.2×	1.6k 1.7×	1.2k 1.3×	1.2k 1.7×	1.7k 3.6×	59	3.9k
Anne Dørum Norway	24	865 0.9×	280 0.3×	553 0.6×	265 0.4×	332 0.7×	71	1.8k
Uziel Beller Israel	25	1.1k 1.1×	485 0.5×	723 0.8×	443 0.6×	971 2.0×	68	3.0k
Jean‐Sébastien Brunet Canada	22	1.4k 1.4×	711 0.8×	1.3k 1.4×	1.2k 1.8×	1.0k 2.2×	26	3.1k
Kathryn P. Pennington United States	15	971 1.0×	340 0.4×	956 1.1×	423 0.6×	818 1.7×	50	2.0k
Claire Palles United Kingdom	17	301 0.3×	604 0.7×	572 0.6×	603 0.9×	634 1.3×	45	1.7k
Barbara M. Norquist United States	21	1.9k 1.9×	659 0.7×	1.8k 2.0×	882 1.3×	1.5k 3.2×	71	3.7k

Countries citing papers authored by Leigha Senter

Since Specialization

Citations

This map shows the geographic impact of Leigha Senter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leigha Senter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leigha Senter more than expected).

Fields of papers citing papers by Leigha Senter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leigha Senter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leigha Senter. The network helps show where Leigha Senter may publish in the future.

Co-authorship network of co-authors of Leigha Senter

This figure shows the co-authorship network connecting the top 25 collaborators of Leigha Senter. A scholar is included among the top collaborators of Leigha Senter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leigha Senter. Leigha Senter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sweet, Kevin, Paul L. Reiter, Patrick Schnell, et al.. (2023). Genetic counseling and testing for females at elevated risk for breast cancer: Protocol for the randomized controlled trial of the Know Your Risk intervention. Contemporary Clinical Trials. 133. 107323–107323. 2 indexed citations

Katz, Mira L., Leigha Senter, Paul L. Reiter, et al.. (2022). Development of a web-based, theory-guided narrative intervention for women at elevated risk for breast cancer. Patient Education and Counseling. 106. 163–169. 1 indexed citations

Phillips, Shannon, et al.. (2022). Hospital-based ovarian cancer patient traceback program results in minimal genetic testing uptake. Gynecologic Oncology. 164(3). 615–621. 6 indexed citations

Kim, Shana J., Jan Lubiński, Tomasz Huzarski, et al.. (2021). Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology Biomarkers & Prevention. 30(11). 2038–2043. 7 indexed citations

Carpenter, Kristen M., et al.. (2020). The impact of a cascade testing video on recipients’ knowledge, cognitive message processing, and affective reactions: A formative evaluation. Journal of Genetic Counseling. 30(3). 656–664. 9 indexed citations

Kotsopoulos, Joanne, Jacek Gronwald, Jeanna McCuaig, et al.. (2020). Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation. Gynecologic Oncology. 159(3). 820–826. 14 indexed citations

Barrington, David A. Mix, et al.. (2020). Niraparib maintenance in frontline management of ovarian cancer: a cost effectiveness analysis. International Journal of Gynecological Cancer. 30(10). 1569–1575. 14 indexed citations

Metcalfe, Kelly, Andrea Eisen, Leigha Senter, et al.. (2019). International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation. British Journal of Cancer. 121(1). 15–21. 102 indexed citations

Kotsopoulos, Joanne, Jacek Gronwald, Henry T. Lynch, et al.. (2018). Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 171(2). 421–426. 10 indexed citations

10.

Nabhan, Fadi, Kyle Porter, Leigha Senter, & Matthew D. Ringel. (2017). Anti-thyroglobulin antibodies do not significantly increase the risk of finding iodine avid metastases on post-radioactive iodine ablation scan in low-risk thyroid cancer patients. Journal of Endocrinological Investigation. 40(9). 1015–1021. 4 indexed citations

11.

Metcalfe, Kelly, Jan Lubiński, Jacek Gronwald, et al.. (2017). The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first‐degree relative with breast cancer. Clinical Genetics. 93(5). 1063–1068. 15 indexed citations

12.

Ni, Ying, Benjamin Fletcher, Todd Romigh, et al.. (2016). Germline compound heterozygous poly-glutamine deletion inUSF3may be involved in predisposition to heritable and sporadic epithelial thyroid carcinoma. Human Molecular Genetics. 26(2). ddw382–ddw382. 13 indexed citations

13.

Liyanarachchi, Sandya, Wei Li, Pearlly S. Yan, et al.. (2016). Genome-Wide Expression Screening Discloses Long Noncoding RNAs Involved in Thyroid Carcinogenesis. The Journal of Clinical Endocrinology & Metabolism. 101(11). 4005–4013. 48 indexed citations

14.

Tomšič, Jerneja, et al.. (2016). HABP2 G534E Variant in Papillary Thyroid Carcinoma. PLoS ONE. 11(1). e0146315–e0146315. 23 indexed citations

15.

Cybulski, Cezary, Jan Lubiński, Tomasz Huzarski, et al.. (2015). Prospective evaluation of alcohol consumption and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 151(2). 435–441. 8 indexed citations

16.

Giannakeas, Vasily, Jan Lubiński, Jacek Gronwald, et al.. (2014). Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study. Breast Cancer Research and Treatment. 147(1). 113–118. 15 indexed citations

17.

Semple, John L., Kelly Metcalfe, Henry T. Lynch, et al.. (2013). International Rates of Breast Reconstruction After Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation Carriers. Annals of Surgical Oncology. 20(12). 3817–3822. 23 indexed citations

18.

McGee, Jacob, Joanne Kotsopoulos, Jan Lubiński, et al.. (2012). Anthropometric Measures and Risk of Ovarian Cancer Among BRCA1 and BRCA2 Mutation Carriers. Obesity. 20(6). 1288–1292. 8 indexed citations

19.

Gururangan, Sridharan, Wendy L. Frankel, Russell Broaddus, et al.. (2007). Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutation. Neuro-Oncology. 10(1). 93–97. 19 indexed citations

20.

Clendenning, Mark, Heather Hampel, Annika Lindblom, et al.. (2006). Long-range PCR facilitates the identification ofPMS2-specific mutations. Human Mutation. 27(5). 490–495. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact